No Data
No Data
Ideaya Biosciences Announced A Research Collaboration With ATTMOS As Part Of Its Efforts To Build A Physics-based Computational Small Molecule Discovery Platform To Target Undruggable Oncology Targets
Express News | IDEAYA Biosciences Announces Collaboration With Attmos to Accelerate AI/ML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets
IDEAYA Biosciences Announces Collaboration With ATTMOS to Accelerate AI/ML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets
Express News | IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
J.P. Morgan Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $63